Eight-Month Absence Of Permanent CEO Signals Impending Centerpulse Sale
This article was originally published in The Gray Sheet
Executive Summary
Centerpulse's still-vacant CEO position after an eight-month search indicates that management may be resigned to selling the company
You may also be interested in...
S&N’s $2.3 Bil. Centerpulse Merger Adds Largest European Orthopedic Player
The acquisition of Centerpulse for $2.3 bil. will allow Smith & Nephew to leapfrog Johnson & Johnson/DePuy and Stryker to become the largest manufacturer of orthopedic implants outside the U.S
S&N’s $2.3 Bil. Centerpulse Merger Adds Largest European Orthopedic Player
The acquisition of Centerpulse for $2.3 bil. will allow Smith & Nephew to leapfrog Johnson & Johnson/DePuy and Stryker to become the largest manufacturer of orthopedic implants outside the U.S
Centerpulse Biologics Unit To Be Split Up Under Evolving Reorganization Plan
Centerpulse's Biologics and Strategic Development Division activities will be integrated into the firm's remaining operating units under a reorganization plan that also includes dismissal of CEO Stephan Rietiker